SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001395064-22-000018
Filing Date
2022-01-14
Accepted
2022-01-14 06:07:32
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13G sc13g-3_011422.htm SC 13G 64938
2 EX-99.1 exhibit991-3_011422.htm EX-99.1 1962
3 EX-99.2 exhibit992-3_011422.htm EX-99.2 7270
  Complete submission text file 0001395064-22-000018.txt   75645
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Subject) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92962 | Film No.: 22530387
SIC: 2834 Pharmaceutical Preparations